EU eyes autumn approval of Pfizer jab for Covid variants

The EU's drug watchdog said it aims to approve this autumn a Pfizer/BioNTech Covid vaccine adapted for two fast-spreading subvariants of the Omicron strain...

Unichem Laboratories gets USFDA's approval to market generic labetalol hydrochloride tablets

Unichem Laboratories Ltd said it has received an approval from the US health regulator to market its generic version of labetalol hydrochloride tablets used to treat high blood pressure...

Charak Pharma launches Fortyfitt Woman tablets

Vedistry, from the house of Charak Pharma announced the launch of a nutritional supplement – Fortyfitt Woman Tablets. Keeping up with Charak’s commitment of delivering well-documented and scientifically researched formulations, FortyFitt Woman...

Cipla betting big on digitisation and emerging sectors

Drug major Cipla is betting big on digitisation and emerging segments like biosimilars and mRNA aided medications to drive its next phase of growth. The Mumbai-based drug maker is also bullish on maximising value opportunity in the complex generics i

JB Pharma reaches revenue growth of 30% to Rs 785 cr in Q1FY23

JB Pharma, one of the fastest growing pharmaceutical companies in India, announced its financial results for the first quarter ended on June 30, 2022.

Importance of Single Use technologies in the Pharma industry

How the speed of single-use equipment adoption by Contract manufacturing organizations is outpacing the speed of biopharma innovators for small and mid-scale bioprocessing.

How one molecule one MRP can Change Pharmaceutical pricing

With the government aiming to introduce TMR on non-scheduled drugs as a measure to reduce the cost of drugs, there has been a significant increase in the number of people who is opposing TMR and is supporting the implementation of the one molecule...

Eli Lilly to make COVID-19 antibody drug commercially available from this month

Eli Lilly and Co said it plans to make its COVID-19 antibody drug commercially available to U.S. states as well as hospitals and other healthcare providers from August...

Strides Pharma gets USFDA approval for generic product

Strides Pharma Science on Wednesday said it has received approval from the US health regulator to market a generic immunosuppressant medication in the American market. The Bengaluru-based company said its step-down wholly-owned subsidiary,...

EU signs deal with HIPRA for COVID vaccines

The European Commission said it had signed a joint procurement contract with Spanish pharmaceutical firm HIPRA for the supply of its protein COVID-19 vaccine, which will be available if approved by the European Medicines Agency (EMA)...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.